Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

1
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (1)

Searched Name

E. M. Wagner‐Drouet

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Dreger P, Martus P, Holtick U, Ayuk F, Wagner‐Drouet EM, Wulf G, Marks R, Penack O, Koenecke C, von Bonin M, von Tresckow B, Stelljes M, Baldus C, Vucinic V, Mougiakakos D, Topp M, Wolff D, Schroers R, Schmitt M, Schmitt T, Lengerke C, Thomas S, Beelen DW, Bethge W. OUTCOME DETERMINANTS OF COMMERCIAL CAR‐T CELL THERAPY FOR LARGE B‐CELL LYMPHOMA: RESULTS OF THE GLA/DRST REAL WORLD ANALYSIS. Hematol Oncol 2021. [DOI: 10.1002/hon.186_2880] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]

Affiliation(s)

P. Dreger German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
P. Martus German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
U. Holtick German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
F. Ayuk German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
E. M. Wagner‐Drouet German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
G. Wulf German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
R. Marks German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
O. Penack German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
C. Koenecke German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
M. von Bonin German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
B. von Tresckow German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
M. Stelljes German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
C. Baldus German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
V. Vucinic German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
D. Mougiakakos German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
M. Topp German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
D. Wolff German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
R. Schroers German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
M. Schmitt German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
T. Schmitt German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
C. Lengerke German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
S. Thomas German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany
D. W. Beelen German Registry for Stem Cell Transplantation DRST Essen Germany
W. Bethge German Lymphoma Alliance Working Group Hematopoietic Cell Therapy Muenster Germany

Collapse